EcoR1 Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-66,665
Closed -$665K 81
2022
Q3
$665K Hold
66,665
0.02% 73
2022
Q2
$658K Hold
66,665
0.02% 72
2022
Q1
$655K Hold
66,665
0.02% 82
2021
Q4
$650K Hold
66,665
0.02% 72
2021
Q3
$655K Hold
66,665
0.02% 65
2021
Q2
$651K Buy
+66,665
New +$66.5K 0.02% 68

EcoR1 Capital's FLACW Position: Q4 2022 in Review

EcoR1 Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 66,665 shares — an estimated $665K sold.

EcoR1 Capital first reported a position in FLACW in Q2 2021 and held it in 6 quarters. The position peaked at $665K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

  • EcoR1 Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • EcoR1 Capital sold 66,665 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $665K.
  • EcoR1 Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2021 and held it in 6 quarters.
  • EcoR1 Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $665K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on EcoR1 Capital's 13F filing for Q4 2022, filed 14 Feb 2023.